[1] Voulgaris T,Sevastianos VA.Atherosclerosis as extrahepatic manifestation of chronic infection with hepatitis C virus. Hepat Res Treat,2016,37(4):394-398. [2] Yamakage A,Ishikawa H.Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica,2009,165(3):186-193. [3] Chen J,Zhang X,Luo H,et al.Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens. Oncotarget,2017,8(53):90916-90924. [4] 中华医学会肝病学分会和感染病学分会. 《丙型肝炎防治指南》2015年更新版.实用肝脏病杂志,2016,19(4):ⅠⅩ-ⅩⅩⅤⅠ. [5] Virlogeux V,Pradat P,Hartig-Lavie K,et al.Interferon-free direct-acting antiviral therapy decreases the rate of hepatocellular carcinoma recurrence in patients with chronic hepatitis C and advanced fibrosis. J Hepatol,2017,66(1):745-751. [6] Meissner EG,Kohli A,Higgins J,et al.Rapid changes in peripheral lymphocyte concentrations during interferon-free treatment of chronic hepatitis C virus infection. Hepatol Commun,2017,1(7):586-594. [7] 郭兆霞,王玉珍,苏少慧. 慢性丙型肝炎患者心血管疾病研究进展. 实用肝脏病杂志,2016,19(6):757-761. [8] 何涛君,杨来智,吴润香,等. 102例慢性丙型肝炎患者血清免疫球蛋白和补体水平变化.实用肝脏病杂志,2015,18(5):538-539. [9] Iom M,Sa DF,Aia NA,et al.Hemochromatosis gene polymorphism as a predictor of sustained virological response to antiviral treatment in Egyptian chronic hepatitis C patients. Euroasian J Hepatogastroenterol,2017,7(2):154-157. [10] Vir P,Fendt L,Amaral K,et al.Prediction of sustained virological response to peginterferon-based therapy for chronic hepatitis C:regression analysis of a cohort from riogrande dosul,brazil. Euroasian J Hepatogastroenterol,2017,7(1):27-33. [11] Mcgary CS,Deleage C,Harper J,et al.CTLA-4(+)PD-1(-) memory CD4(+) T cells critically contribute to viral persistence in antiretroviral therapy-suppressed,SIV-infected rhesus macaques. Immunity,2017,47(4):776-788. [12] Miller SM, Miles B,Guo K,et al.Follicular regulatory T cells are highly permissive to R5-tropic HIV-1. J Virol,2017,91(17):11-17. [13] Ayala VI,Deleage C,Trivett MT,et al.CXCR5 dependent entry of CD8 T cells into rhesus macaque B-cell follicles achieved through T-Cell engineering. J Virol,2017,91(11):1-8. [14] Amiezer M,Phan TG.Disentangling Tfr cells from Treg cells and Tfh cells:how to untie the gordian knot. Eur J Immunol,2016,46(5):1101-1104. [15] Kohler SL,Pham MN,Folkvord JM,et al.Germinal center T follicular helper cells are highly permissive to HIV-1 and alter their phenotype during virus replication. J Immunol,2016,196(6):2711-2722. [16] Elela MA,Gawdat HI,Hegazy RA,et al.B cell activating factor and T-helper 17 cells:possible synergistic culprits in the pathogenesis of Alopecia Areata. Arch Dermatol Res,2016,308(2):115-121. [17] Lang Q,Xu W,Li X,et al.Differential expression profile of immunological cytokines in local ovary in patients with polycystic ovarian syndrome:analysis by flow cytometry. Eur J Obstet Gynecol Reprod Biol,2016,197(1):136-141. [18] Chowdhury A,Pm DRE,Tharp GK,et al.Decreased T follicular regulatory cell/T follicular helper cell(TFH) in simian Immunodeficiency virus-infected rhesus macaques may contribute to accumulation of TFH in chronic infection. J Immunol,2015,195(7):3237-3247. [19] Wang C,Zhu H,Zhou Y,et al.Prognostic value of PD-L1 in breast cancer:a Meta-analysis. Breast J,2017,23(4):436-443. [20] Morganstein DL,Lai Z,Spain L,et al.Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma. Clin Endocrinol (Oxf),2017,86(4):614-620. |